Most Recent
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
Isuzu is not giving up its bid to slam the brakes on a suit by car alarm company Directed Electronics over alleged trade secrets theft.
Vehicle maker Isuzu can't shut down an $18 million suit by car alarm company Directed Electronics over a former employee’s alleged theft of trade secrets.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
The maker of Mother energy drinks has won an appeal of an IP Australia decision, succeeding in its bid to prevent a Victoria-based company from registering Kangaroo Mother as a trade mark for beverages.
Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen's genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.
Retail giant Cotton On has hit back at allegations of copyright infringement, highlighting the prevalence of copying in the fashion industry.